APPLICATION
ANDA074479
TYPE
ANDA
ORIGINAL APPROVAL
1997-01-21
LATEST ACTION
2001-06-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued
Products
ALPRAZOLAMDiscontinued
ALPRAZOLAM 1MG · TABLET · ORAL
ALPRAZOLAMDiscontinued
ALPRAZOLAM 0.25MG · TABLET · ORAL
ALPRAZOLAMDiscontinued
ALPRAZOLAM 0.5MG · TABLET · ORAL
Approval history
2001-06-21Labeling · Supplement 9AP
2001-04-12Manufacturing (CMC) · Supplement 8AP
2000-09-19Labeling · Supplement 7AP
2000-03-21Manufacturing (CMC) · Supplement 6AP
1999-05-21Manufacturing (CMC) · Supplement 5AP
1998-12-14Manufacturing (CMC) · Supplement 4AP
1998-08-21Manufacturing (CMC) · Supplement 3AP
1998-04-20Manufacturing (CMC) · Supplement 2AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.